These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 9395464)

  • 21. Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein.
    Weisgraber KH; Mahley RW; Kowal RC; Herz J; Goldstein JL; Brown MS
    J Biol Chem; 1990 Dec; 265(36):22453-9. PubMed ID: 2266137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL.
    Larsson M; Allan CM; Jung RS; Heizer PJ; Beigneux AP; Young SG; Fong LG
    J Lipid Res; 2017 Sep; 58(9):1893-1902. PubMed ID: 28694296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent regulation of plasma apolipoprotein C-II and C-III concentrations in very low density and high density lipoproteins: implications for the regulation of the catabolism of these lipoproteins.
    Le NA; Gibson JC; Ginsberg HN
    J Lipid Res; 1988 May; 29(5):669-77. PubMed ID: 3411241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDL 29311, a phenolic antioxidant, interferes with the interaction of apoC with VLDL: a possible explanation for its triglyceride-lowering effect.
    Sheetz MJ
    J Lipid Res; 1995 Dec; 36(12):2609-21. PubMed ID: 8847487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apolipoprotein and lipid distribution between vesicles and HDL-like particles formed during lipolysis of human very low density lipoproteins by perfused rat heart.
    Tam SP; Breckenridge WC
    J Lipid Res; 1983 Oct; 24(10):1343-57. PubMed ID: 6644185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lipolysis stimulated lipoprotein receptor: a novel molecular link between hyperlipidemia, weight gain, and atherosclerosis in mice.
    Yen FT; Roitel O; Bonnard L; Notet V; Pratte D; Stenger C; Magueur E; Bihain BE
    J Biol Chem; 2008 Sep; 283(37):25650-25659. PubMed ID: 18644789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ApoC-III Glycoforms Are Differentially Cleared by Hepatic TRL (Triglyceride-Rich Lipoprotein) Receptors.
    Kegulian NC; Ramms B; Horton S; Trenchevska O; Nedelkov D; Graham MJ; Lee RG; Esko JD; Yassine HN; Gordts PLSM
    Arterioscler Thromb Vasc Biol; 2019 Oct; 39(10):2145-2156. PubMed ID: 31390883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoprotein lipase-catalyzed hydrolysis of phosphatidylcholine of guinea pig very low density lipoproteins and discoidal complexes of phospholipid and apolipoprotein: effect of apolipoprotein C-II on the catalytic mechanism.
    Shirai K; Fitzharris TJ; Shinomiya M; Muntz HG; Harmony JA; Jackson RL; Quinn DM
    J Lipid Res; 1983 Jun; 24(6):721-30. PubMed ID: 6688442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.
    Wolska A; Dunbar RL; Freeman LA; Ueda M; Amar MJ; Sviridov DO; Remaley AT
    Atherosclerosis; 2017 Dec; 267():49-60. PubMed ID: 29100061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibitory effects of C apolipoproteins from rats and humans on the uptake of triglyceride-rich lipoproteins and their remnants by the perfused rat liver.
    Windler E; Havel RJ
    J Lipid Res; 1985 May; 26(5):556-65. PubMed ID: 4020294
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous triglyceride-rich lipoproteins accumulate in rat plasma when competing with a chylomicron-like triglyceride emulsion for a common lipolytic pathway.
    Karpe F; Hultin M
    J Lipid Res; 1995 Jul; 36(7):1557-66. PubMed ID: 7595079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of apolipoprotein E isoforms on lipolysis of very low-density lipoprotein triglycerides.
    Hara M; Iso-O N; Satoh H; Noto H; Togo M; Ishibashi S; Kimura S; Kadowaki T; Hashimoto Y; Tsukamoto K
    Metabolism; 2006 Aug; 55(8):1129-34. PubMed ID: 16839851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A human APOC3 missense variant and monoclonal antibody accelerate apoC-III clearance and lower triglyceride-rich lipoprotein levels.
    Khetarpal SA; Zeng X; Millar JS; Vitali C; Somasundara AVH; Zanoni P; Landro JA; Barucci N; Zavadoski WJ; Sun Z; de Haard H; Toth IV; Peloso GM; Natarajan P; Cuchel M; Lund-Katz S; Phillips MC; Tall AR; Kathiresan S; DaSilva-Jardine P; Yates NA; Rader DJ
    Nat Med; 2017 Sep; 23(9):1086-1094. PubMed ID: 28825717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential metabolism of human VLDL according to content of ApoE and ApoC-III.
    Tomiyasu K; Walsh BW; Ikewaki K; Judge H; Sacks FM
    Arterioscler Thromb Vasc Biol; 2001 Sep; 21(9):1494-500. PubMed ID: 11557678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of plasma apolipoproteins on lipoprotein lipase-mediated lipolysis of small and large lipid emulsions.
    Yamamoto M; Morita SY; Kumon M; Kawabe M; Nishitsuji K; Saito H; Vertut-Doï A; Nakano M; Handa T
    Biochim Biophys Acta; 2003 Jun; 1632(1-3):31-9. PubMed ID: 12782148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disparities in the interaction of rat and human lipoproteins with cultured rat fibroblasts and smooth muscle cells. Requirements for homology for receptor binding activity.
    Innerarity TL; Pitas RE; Mahley RW
    J Biol Chem; 1980 Dec; 255(23):11163-72. PubMed ID: 6254962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.
    Zheng C; Khoo C; Ikewaki K; Sacks FM
    J Lipid Res; 2007 May; 48(5):1190-203. PubMed ID: 17314277
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E structure and substrate and receptor-binding activities of triglyceride-rich human plasma lipoproteins in normo- and hypertriglyceridemia.
    Dergunov AD
    Biochemistry (Mosc); 2004 Jul; 69(7):720-37. PubMed ID: 15310270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.